Literature DB >> 32496102

Commentary on the coronavirus pandemic: Anticipating a fourth wave in the opioid epidemic.

Molly McCann Pineo1, Rebecca M Schwartz1.   

Abstract

Experiencing the COVID-19 pandemic simultaneously with the U.S. opioid epidemic is anticipated to have a profound mental health impact on some of our most vulnerable populations. Recent federal and state regulatory changes have been made under the state of emergency in order to ameliorate the some of the challenges faced in maintaining access to substance use and addiction services during such times. There are currently considerable limitations in quantifying the impact of COVID-19 among those with substance use disorders, however, it is imperative that health care systems continue to serve this population in order to prevent associated morbidity and mortality. (PsycInfo Database Record (c) 2020 APA, all rights reserved).

Entities:  

Mesh:

Year:  2020        PMID: 32496102     DOI: 10.1037/tra0000622

Source DB:  PubMed          Journal:  Psychol Trauma        ISSN: 1942-969X


  6 in total

1.  "How will I get my next week's script?" Reactions of Reddit opioid forum users to changes in treatment access in the early months of the coronavirus pandemic.

Authors:  Noa Krawczyk; Amanda M Bunting; David Frank; Joshua Arshonsky; Yuanqi Gu; Samuel R Friedman; Marie A Bragg
Journal:  Int J Drug Policy       Date:  2021-02-06

2.  Big Events theory and measures may help explain emerging long-term effects of current crises.

Authors:  Samuel R Friedman; Pedro Mateu-Gelabert; Georgios K Nikolopoulos; Magdalena Cerdá; Diana Rossi; Ashly E Jordan; Tarlise Townsend; Maria R Khan; David C Perlman
Journal:  Glob Public Health       Date:  2021-04-11

3.  Harm reduction in the time of COVID-19: Case study of homelessness and drug use in Dublin, Ireland.

Authors:  Austin O'Carroll; Tony Duffin; John Collins
Journal:  Int J Drug Policy       Date:  2020-11-07

4.  External validation of an opioid misuse machine learning classifier in hospitalized adult patients.

Authors:  Majid Afshar; Brihat Sharma; Sameer Bhalla; Hale M Thompson; Dmitriy Dligach; Randy A Boley; Ekta Kishen; Alan Simmons; Kathryn Perticone; Niranjan S Karnik
Journal:  Addict Sci Clin Pract       Date:  2021-03-17

5.  Identifying New/Emerging Psychoactive Substances at the Time of COVID-19; A Web-Based Approach.

Authors:  Valeria Catalani; Davide Arillotta; John Martin Corkery; Amira Guirguis; Alessandro Vento; Fabrizio Schifano
Journal:  Front Psychiatry       Date:  2021-02-09       Impact factor: 4.157

Review 6.  Neuropsychiatric Complications of COVID-19.

Authors:  Zev M Nakamura; Rebekah P Nash; Sarah L Laughon; Donald L Rosenstein
Journal:  Curr Psychiatry Rep       Date:  2021-03-16       Impact factor: 5.285

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.